Abstract:Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder. Affecting 5%-10% 1 Li R. Zhang Q. Yang D. Li S. Lu S. Wu X. et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013; 28: 2562-2569 Crossref PubMed Scopus (188) Google Scholar of reproductive-aged women, PCOS is characterized by hyperandrogenemia, anovulation, and insulin resistance (IR), with long-term effects throughout the different stages of a woman's life. During gestation, women with PCOS have greater androgen concentrations. 2 Sir-Petermann T. Maliqueo M. Angel B. Lara H.E. Perez-Bravo F. Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002; 17: 2573-2579 Crossref PubMed Google Scholar Intrauterine exposure to high androgen concentrations may cause fetal reprogramming or placental changes through epigenetic regulation or other mechanisms, thus causing changes in multiple systems in the offspring and ultimately affecting growth and development. The hormonal and metabolic alterations have been found in brothers of women with PCOS, 3 Sam S. Coviello A.D. Sung Y.A. Legro R.S. Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008; 31: 1237-1241 Crossref PubMed Scopus (45) Google Scholar ,4 Torchen L.C. Kumar A. Kalra B. Savjani G. Sisk R. Legro R.S. et al. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016; 106: 50-55 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar which may reflect the effects of PCOS susceptibility genes or programming effects of the intrauterine environment. Furthermore, a greater risk of pregnancy complications, 5 Palomba S. de Wilde M.A. Falbo A. Koster M.P. La Sala G.B. Fauser B.C. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015; 21: 575-592 Crossref PubMed Scopus (163) Google Scholar , 6 Damm P. Houshmand-Oeregaard A. Kelstrup L. Lauenborg J. Mathiesen E.R. Clausen T.D. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016; 59: 1396-1399 Crossref PubMed Scopus (182) Google Scholar , 7 Walker C.K. Krakowiak P. Baker A. Hansen R.L. Ozonoff S. Hertz-Picciotto I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr. 2015; 169: 154-162 Crossref PubMed Scopus (136) Google Scholar the use of metformin during pregnancy, 8 Rowan J.A. Rush E.C. Plank L.D. Lu J. Obolonkin V. Coat S. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018; 6: e000456 Crossref PubMed Google Scholar and maternal metabolic abnormalities (including obesity or IR 9 Drake A.J. Reynolds R.M. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction. 2010; 140: 387-398 Crossref PubMed Scopus (278) Google Scholar ,10 Fusco S. Spinelli M. Cocco S. Ripoli C. Mastrodonato A. Natale F. et al. Maternal insulin resistance multigenerationally impairs synaptic plasticity and memory via gametic mechanisms. Nat Commun. 2019; 10: 4799 Crossref PubMed Scopus (0) Google Scholar ) may be implicated in the effects on offspring.

LHCGR and ALMS1 defects likely cooperate in the development of polycystic ovary syndrome indicated by double-mutant mice

The Casein Kinase 2α Promotes the Occurrence Polycystic Ovary Syndrome.

PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

Aberrant Expression and DNA Methylation of Lipid Metabolism Genes in PCOS: a New Insight into Its Pathogenesis.

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

LncRNA SNHG5 Adversely Governs Follicular Growth in PCOS Via Mir-92A-3p/cdkn1c Axis

Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview

Multiomics Analysis Reveals Molecular Abnormalities in Granulosa Cells of Women With Polycystic Ovary Syndrome

Aberrant activation of the Hedgehog signaling pathway in granulosa cells from patients with polycystic ovary syndrome

Hypomethylation of the LH/choriogonadotropin Receptor Promoter Region is a Potential Mechanism Underlying Susceptibility to Polycystic Ovary Syndrome.

Attenuated Expression of MTR in Both Prenatally Androgenized Mice and Women with the Hyperandrogenic Phenotype of PCOS

Testosterone-induced H3K27 deacetylation participates in granulosa cell proliferation suppression and pathogenesis of Polycystic Ovary Syndrome

Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models

miRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients

Significant Alteration of Protein Profiles in a Mouse Model of Polycystic Ovary Syndrome.

Association of the Genetic Variants of Luteinizing Hormone, Luteinizing Hormone Receptor and Polycystic Ovary Syndrome

Downregulation of CASC15 attenuates the symptoms of polycystic ovary syndrome by affecting granulosa cell proliferation and regulating ovarian follicular development

Long Non-Coding RNA Lnc-CCNL1-3:1 Promotes Granulosa Cell Apoptosis and Suppresses Glucose Uptake in Women with Polycystic Ovary Syndrome

Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome